INHIBITORI PROTEIN KINAZE C I POSTUPCI ZA NJIHOVU UPOTREBU

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

LUZZIO, MICHAEL, JOSEPH,PAPILLON, JULIEN,VISSER, MICHAEL, SCOTT

申请号：

RSP20191472

公开号：

RS59692B1

申请日:

2015.08.05

申请国别(地区):

RS

年份:

2020

代理人:

摘要：

PKC inhibitors are disclosed. The PKC inhibitors are useful for treating PKC associated diseases, including certain cancers. The PKC inhibitors have improved efficacy at lower dosage amounts to achieve tumor regression, improved potency, PK profile, absorption, gastrointestinal tolerance and kinase selectivity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/